๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hypertension
Clinical trial register · China

Hypertension Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 36 Shanghai 14 Chongqing 12 Nanjing 6 Chengdu 6
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking University5 China National Center for Cardiovascular Diseases5 Shanghai Jiao Tong University School of Medicine3 Eli Lilly and Company3 Jing Liu3
Site location
Beijing36 Shanghai14 Chongqing12 Nanjing6 Chengdu6
All 60 locations
Target enrolment
to

Hypertension trials in China

89 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
EECP for Erectile Dysfunction in Elderly Hypertensive Patients
NCT07831551Hypertension, Erectile Dysfunction
Qilu Hospital of Shandong University
Not applicable
106
Shenzhen, Jinan
2026-10-01
Not yet open
CEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity
NCT07778771Stroke, Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity
Duke Kunshan University
Not applicable
365
Kunshan
2026-08-31
Not yet open
A Blood Pressure-Lowering Diet for Preventing and Managing Hypertension
NCT07735091Hypertension
Peking University
Not applicable
800
Dongying
2026-08-01
Not yet open
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory Failure
NCT07603037Acute Respiratory Failure (ARF), Hypertension, Pulmonary Perfusion Imbalance, Aortic Dissection (Subset)
DrugNicardipine
First Affiliated Hospital of Wannan Medical College
Not applicable
12
Wuhu
2026-07-15
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Not yet open
Songling Xuemaikang in Hypertension and Insomnia Evaluation๏ผˆSHINE๏ผ‰
NCT07709442Hypertension
DrugSongling Xuemaikang
Jing Liu
Not applicable
260
Beijing
2026-06-30
Recruiting
Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt)
NCT07614724Salt-Sensitivity of Blood Pressure, Hypertension
Peking University
Not applicable
72
Beijing
2026-06-02
Not yet open
Study of IBI3016 in People With Mild or Moderate Hypertension Patients
NCT07556796Hypertension
DrugIBI3016
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Beijing
2026-05-15
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Active, closed
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NCT07350486Hypertension, Diabetes, Dyslipidemia
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Not yet open
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis
NCT07566065Atherosclerotic Renal Artery Stenosis, Hypertension, Renal Artery Stenosis
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
150
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Jinan, Qingdao
2026-04-30
Recruiting
Auricular Acupuncture Therapy Administered by Village Doctors Improves Sleep Quality in Elderly Patients With Comorbid Diabetes Mellitus and Hypertension
NCT07554235Insomnia Disorder, Diabetes, Hypertension
Jiangsu Taizhou People's Hospital
Not applicable
320
Taizhou
2026-04-22
Recruiting
A Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District
NCT07804420Hypertension
Peking University
Not applicable
500
Beijing
2026-04-01
Not yet open
Chronic Kidney Disease and Metabolic Disorders in the Elderly
NCT07494526Chronic Kidney Diease, Diabetes Mellitus, Hypertension, Hyperlipidemia
Chinese PLA General Hospital
Observational
100,000
Beijing
2026-04
Active, closed
A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
NCT07360275Hypertension
DrugCX11
Vincentage Pharma Co., Ltd
Phase 2
160
Beijing
2026-03-01
Not yet open
A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
NCT07352969Hypertension
DrugIBI3016
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
352
Beijing
2026-02-06
Not yet open
Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension
NCT06783296Hypertension, Renal Denervation Therapy
Shanghai 10th People's Hospital
Not applicable
124
Shanghai
2026-01-01
Not yet open
The Workplace-Based Hypertension Management Program
NCT07265193Hypertension
Guangxi Medical University
Not applicable
512
Nanning
2026-01
Not yet open
Songling Xuemaikang Capsules for Cerebral Small Vessel Disease
NCT07271732Hypertension, Cerebral Small Vessel Diseases
DrugSongling Xuemaikang
Dongzhimen Hospital, Beijing
Not applicable
90
Beijing
2025-12-10
Not yet open
Efficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation
NCT07239492Hypertension, Hypotension
Xuanwu Hospital, Beijing
Not applicable
25
Beijing
2025-12-01
Not yet open
Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
NCT07241338Hypertension
DrugAmlodipine
Jing Liu
Phase 4
104
Beijing
2025-11
Recruiting
VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
NCT07254481Hypertension
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 1
86
Hangzhou, Shanghai
2025-10-05
Recruiting
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
NCT06615609Post Coronary Artery Bypass Grafting, Hypertension, Diabetes Mellitus, Hyperlipidemia
China National Center for Cardiovascular Diseases
Not applicable
536
รœrรผmqi
2025-09-24
Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
DrugZilebesiran
Alnylam Pharmaceuticals
Phase 3
11,000
Beijing, Binhai, Changchun, Changsha, Chengdu, Chongqing, Dalian, Datong
2025-09-22
By invitation
A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease
NCT07130955Hypertension, CKD - Chronic Kidney Disease
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
236
Beijing
2025-08-08
By invitation
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDN
NCT07273877Hypertension
Shanghai Golden Leaf MedTec Co. Ltd
Observational
1,000
Beijing
2025-08-07
Recruiting
To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
NCT07191899Hypertension
DrugKN060
Suzhou Alphamab Co., Ltd.
Phase 1
60
Shanghai
2025-08-05
Recruiting
Taining Golden Lake Comprehensive Chronic Disease Management Initiative
NCT07308314Chronic Disease, Chronic Disease Management, Hypertension, Diabetes Mellitus
First Affiliated Hospital of Fujian Medical University
Observational
20,000
Fuzhou
2025-08-01
Recruiting
EASi-PROTKTโ„ข - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
DrugsVicadrostat·Empagliflozin
Boehringer Ingelheim
Phase 3
11,800
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian
2025-07-22
Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
NCT07043166Metabolic Syndrome, Diabetes, Obesity and Overweight, Hypertension
Shanghai Changzheng Hospital
Observational
4,094
Shanghai
2025-07-01
Not yet open
Intervention Study on Digital Health Management
NCT06949306Hypertension, Hyperlipidemia
Shanghai 10th People's Hospital
Not applicable
300
Shanghai
2025-07-01
Recruiting
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
NCT06558877Hypertension
Xijing Hospital
Not applicable
1,200
Xi'an
2025-06-20
Active, closed
Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity
NCT06975501Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity, Stroke
Duke Kunshan University
Not applicable
444
Suzhou
2025-06-20
Recruiting
Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach
NCT06869031Hypertension Self-management, Hypertension
Yuju Wu
Not applicable
320
Chengdu
2025-06-01
Recruiting
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
NCT07400549Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing
2025-06-01
Not yet open
Etiological Classification-guided Individual Intervention in Primary Hypertension
NCT06941935Hypertension
Shanghai 10th People's Hospital
Not applicable
2,000
Shanghai
2025-06-01
Recruiting
Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial
NCT06828692Hypertension
China National Center for Cardiovascular Diseases
Not applicable
2,160
Shenzhen
2025-05-26
Recruiting
Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
NCT07552571Hypertension, Diabetes Mellitus, Dyslipidemia
Xiong Juyang
Not applicable
600
Wuhan
2025-05-15
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
NCT06948435Hypertension, Overweight or Obesity
DrugOrforglipron
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
NCT06952530Hypertension
DrugOrforglipron
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
NCT06948422Hypertension
DrugOrforglipron
Eli Lilly and Company
Phase 3
974
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513Hypertension, Diabetes, Atrial Fibrillation, Dyslipidemia
Affiliated Hospital of Nantong University
Not applicable
300
Nantong
2025-04-20
Recruiting
Steroids-Based Screening for Primary Aldosteronism
NCT06941116Primary Aldosteronism, Hypertension
Qifu Li
Observational
406
Chongqing
2025-04-15
Recruiting
Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension
NCT06829134Hypertension, Retroperitoneal Disease
Ruijin Hospital
Not applicable
246
Shanghai
2025-03-01
Recruiting
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
NCT07482020Atrial Fibrillation (AF), Hypertension
Huashan Hospital
Phase 2
66
Shanghai
2025-03-01
Not yet open
Standardized Antihypertensive Treatment Protocol
NCT06790927Hypertension
Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2025-02-24
Recruiting
Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery
NCT07019246Etomidate Combined With Propofol, Hypertension
DrugPropofol
Tongji Hospital
Not applicable
166
Wuhan
2025-02-01
Not yet open
SMART Study in Real World
NCT06780696Hypertension, Uncontrolled Hypertension, Resistant Hypertension, Reduce Antihypertensive Drug Burden
SyMap Medical (Suzhou), Ltd.
Observational
1,000
Beijing
2025-02
Not yet open
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
NCT06760078Spontaneous Intracranial Hemorrhage, Hypertension
DrugTranexamic acid (TXA)
Xuanwu Hospital, Beijing
Phase 4
532
Beijing
2024-12-31
By invitation
Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community
NCT06512922Hypertension, Condition, Aging
Peking University
Not applicable
120
Beijing
2024-10-29
Recruiting
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
NCT07180368Coronary Artery Disease, Diabete Mellitus, Chronic Kidney Disease, Hypertension
Xijing Hospital
Observational
2,000
Xi'an
2024-10-01
Recruiting
The Effect of Interventions for Health Behaviors in Hypertensive Patients
NCT06640751Hypertension, Health Behavior, Public Health
Nanjing Medical University
Not applicable
240
Nanjing
2024-10-01
Recruiting
Statin Combined with Amlodipine Treats Primary Aldosteronism
NCT06523465Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, Hypertension
Third Military Medical University
Phase 4
180
Chongqing
2024-09-10
Recruiting
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
NCT04974138Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcyโ‰ฅ10ยตmol/L), Insufficient Plasma Folate Levels (<12ng/mL)
DrugsAmlodipine besylate·Amlodipine besylate and folic acid·Amlodipine
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4
32,000
Bengbu, Bozhou, Chizhou, Fuyang, Beijing, Yangjiang, Guiyang, Huaihua
2024-08-22
Recruiting
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
NCT04974151Hypertension, MTHFR 677 TT Genotype
DrugsAmlodipine besylate·Amlodipine besylate and folic acid·Amlodipine
Shenzhen Ausa Pharmed Co.,Ltd
Phase 4
24,000
Bengbu, Bozhou, Chizhou, Fuyang, Beijing, Yangjiang, Guiyang, Huaihua
2024-08-22
Active, closed
Health Behavior Nudge Strategies for Chronic Disease Patients: the Study of Hypertension and Type 2 Diabetes
NCT06588127Economics, Behavioral, Hypertension, Type 2 Diabetes Mellitus (T2DM), Self-management Behavior
Lin Han
Not applicable
133
Lanzhou
2024-07-01
Recruiting
County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
NCT06302127Hypertension, Diabetes Mellitus Type 2, Cardiovascular Diseases
Peking University
Not applicable
2,560
Sanming, Liuzhou
2024-05-20
Recruiting
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)
NCT06283758Hypertension, Blood Pressure, Cardiovascular Diseases
Suzhou Municipal Hospital
Not applicable
30
Nanjing, Nantong, Suzhou
2024-03-01
Recruiting
Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
NCT07149688Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD), Heart Failure
Beijing Anzhen Hospital
Observational
30,000
Beijing
2024-03-01
Recruiting
Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
NCT06055452Pre-Heart Failure, Hypertension
DrugsJardiance·Empagliflozin
China National Center for Cardiovascular Diseases
Phase 4
120
Beijing, Shenzhen
2024-01-19
Not yet open
Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension
NCT05416840Hypertension
DrugAmlodipine
Jing Liu
Phase 4
92
Beijing
2024-01
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Nanjing
2023-12-27
Active, closed
Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
NCT05749874PreDiabetes, Abdominal Obesity, Hypertension, Dyslipidemias
DrugBerberine
China National Center for Cardiovascular Diseases
Phase 4
2,024
Beijing
2023-10-31
Active, closed
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
NCT05824923Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension, Vascular Diseases
Pulnovo Medical (Wuxi) Co., Ltd.
Phase 3
264
Shenyang
2023-08-14
By invitation
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
NCT05688579Hypertension, Hyperaldosteronaemia
Nanfang Li
Phase 4
8,000
รœrรผmqi
2023-04-16
Recruiting
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
NCT05590871Hypertension
Shanghai Hongdian Medical CO., LTD
Not applicable
180
Chongqing, Xiamen, Lanzhou, Guangzhou, Guiyang, Harbin, Zhengzhou, Zhenzhou
2023-03-31
Recruiting
Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China
NCT05735444Hypertension, Obstructive Sleep Apnea
Shanghai Jiao Tong University School of Medicine
Observational
633
Shanghai
2023-01-01
Not yet open
Effect of Prebiotics on Blood Pressure Management
NCT05364736Hypertension, Gastrointestinal Microbiome
Sun Yat-sen University
Not applicable
100
Guangzhou
2022-10-17
Recruiting
Clinical Indicators and Brain Image Data: a Study Based on Kailuan Cohort
NCT05453877Brain Diseases, Hypertension
Beijing Friendship Hospital
Observational
1,000
Beijing, Tangshan
2022-08-01
Recruiting
Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
NCT05476627Chronic Kidney Diseases, Hypertension, Diabetes Mellitus, Hyperuricemia
Peking Union Medical College Hospital
Observational
200
Beijing
2022-07-01
Recruiting
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
NCT05638503Hypertension
Qilu Hospital of Shandong University
Observational
2,200
Jinan
2022-05-01
Recruiting
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
NCT07137364Primary Aldosteronism, Hypertension
Third Military Medical University
Observational
350
Chongqing
2022-05-01
Recruiting
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
NCT05644548Hypertension, Diabetes Mellitus, Dyslipidemias
Beijing Tongren Hospital
Observational
300
Beijing
2022-03-01
Recruiting
Integrated Diagnosis and Treatment of CKD on Outcomes
NCT05242055Chronic Kidney Diseases, Hypertension, Hyperglycemia, Hyperlipidemias
Capital Medical University
Observational
1,000
Beijing
2022-02-01
Recruiting
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
NCT05498675Sacubitril/Valsartan, Hypertension, Obesity
DrugsSacubitril/valsartan·ACEI/ARB
Beijing Friendship Hospital
Observational
180
Beijing
2021-09-01
Recruiting
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
NCT04753840Hypertension
Henan Institute of Cardiovascular Epidemiology
Not applicable
400
Zhengzhou
2021-07-03
Recruiting
Morning Versus Bedtime Dosing of Antihypertensive Medication
NCT05089448Hypertension, Blood Pressure, Drug Use
Yan Li
Phase 4
300
Shanghai
2021-01-28
By invitation
Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease
NCT07033676Hypertension, Heart Disease
The University of Hong Kong-Shenzhen Hospital
Observational
46
Shenzhen
2021-01-01
Recruiting
Environment, Inflammation and Metabolic Diseases Study
NCT07512609Endocrine Disease, Metabolic Disorders, Hypertension, Diabetes Mellitus
Qifu Li
Observational
8,000
Chongqing
2020-12-25
Active, closed
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
NCT04111419Atrial Fibrillation, Hypertension
DrugAllisartan Isoproxil
Shanghai Jiao Tong University School of Medicine
Phase 4
1,200
Shanghai
2020-07-01
Recruiting
Prognostic Model of Hypertension
NCT06160921Hypertension
Xinjiang Medical University
Observational
50,000
รœrรผmqi
2020-01-01
Recruiting
A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
NCT04212455Hypertension, Cardiovascular Diseases
Guangdong Provincial People's Hospital
Observational
50,000
Guangzhou
2020-01-01
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Beijing, Guangzhou, Changsha, Shanghai
2019-09-23
Recruiting
A Prospective Nurse Cohort Study in Xiamen, China
NCT03799653Hypertension
The First Affiliated Hospital of Xiamen University
Observational
10,000
Xiamen
2019-03-20
Recruiting
Effect of Bariatric Surgery on Cardiac Function in Patients With Hypertension
NCT05166954Bariatric Surgery, Hypertension
Beijing Friendship Hospital
Observational
40
Beijing
2018-08-01
Recruiting
A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
NCT03547856Hypertension, Blood Pressure, Cardiovascular Diseases
Yan Li
Observational
10,000
Shanghai
2018-07-18
Recruiting
Nanshan Elderly Cohort Study
NCT03569735Hypertension, Type 2 Diabetes Mellitus, Cardiovascular Diseases, Stroke
Sun Yat-sen University
Observational
20,000
Shenzhen, Guangzhou
2018-05-26
Active, closed
China Rural Hypertension Control Project
NCT03527719Hypertension
First Hospital of China Medical University
Not applicable
33,995
Shenyang
2018-05-08
Active, closed
Sympathetic Mapping/ Ablation of Renal Nerves Trial
NCT02761811Hypertension
SyMap Medical (Suzhou), Ltd.
Not applicable
220
Beijing, Chongqing, Shenzhen, Shijiazhuang, Daqing, Wuhan, Nanjing, Xuzhou
2016-06-30
Rows per page Showing 1–89 of 89
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/hypertension

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 89 of those studies listing the condition Hypertension.

How many Hypertension trials are recruiting in China?

50 of the 89 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 21 have not yet opened recruitment, 12 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hypertension), 89 studies
PhaseStudiesRecruitingShare
Not applicable401944.9%
Observational242027%
Phase 412613.5%
Phase 3727.9%
Phase 1323.4%
Phase 2313.4%

Most active sponsors

Lead sponsors with the most studies (Hypertension)
Lead sponsorStudiesRecruiting
China National Center for Cardiovascular Diseases54
Peking University53
Beijing Friendship Hospital33
Eli Lilly and Company30
Jing Liu30
Shanghai 10th People's Hospital30
Shanghai Jiao Tong University School of Medicine31
Beijing Anzhen Hospital22
Duke Kunshan University20
First Hospital of China Medical University20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.